{"transactions":[{"id":742973,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T00:11:51.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":65600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 9, 2027 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":65600,"derivative":{"exercise_price":7.25,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":65600},"source":{"system":"sec-edgar","filing":"0001371407-26-000003","document":"wk-form4_1781136707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000137140726000003/wk-form4_1781136707.xml","form_type":"4"}},{"id":1104893,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-20T22:34:38.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":162786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 18, 2026 or the date immediately preceding the Issuer's next annual meeting of stockholders."}],"balance_after":162786,"derivative":{"exercise_price":2.84,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":162786},"source":{"system":"sec-edgar","filing":"0001326110-25-000092","document":"wk-form4_1750458872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000092/wk-form4_1750458872.xml","form_type":"4"}},{"id":1480429,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T22:49:17.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":77633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 11, 2025 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":77633,"derivative":{"exercise_price":5.96,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":77633},"source":{"system":"sec-edgar","filing":"0001326110-24-000077","document":"wk-form4_1718318948.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000077/wk-form4_1718318948.xml","form_type":"4"}},{"id":1854133,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T22:24:17.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":158263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 13, 2024 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":158263,"derivative":{"exercise_price":2.99,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":158263},"source":{"system":"sec-edgar","filing":"0001326110-23-000084","document":"wk-form4_1686867846.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000084/wk-form4_1686867846.xml","form_type":"4"}},{"id":1866720,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:52:51.000Z","date":"2023-06-05","kind":"purchase","planned":false,"acquired":true,"shares":485,"price":2.75,"value":1333.75,"ownership":{"direct":false,"nature":"By trust"},"balance_after":71915,"source":{"system":"sec-edgar","filing":"0001326110-23-000072","document":"wk-form4_1686016361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000072/wk-form4_1686016361.xml","form_type":"4"}},{"id":1866719,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:52:51.000Z","date":"2023-06-05","kind":"purchase","planned":false,"acquired":true,"shares":48000,"price":2.77,"value":132960.0,"ownership":{"direct":false,"nature":"By trust"},"balance_after":71430,"source":{"system":"sec-edgar","filing":"0001326110-23-000072","document":"wk-form4_1686016361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000072/wk-form4_1686016361.xml","form_type":"4"}},{"id":1866718,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:52:51.000Z","date":"2023-06-05","kind":"purchase","planned":false,"acquired":true,"shares":23430,"price":2.72,"value":63729.6,"ownership":{"direct":false,"nature":"By trust"},"balance_after":23430,"source":{"system":"sec-edgar","filing":"0001326110-23-000072","document":"wk-form4_1686016361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000072/wk-form4_1686016361.xml","form_type":"4"}},{"id":2231329,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T01:16:59.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":167937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 14, 2023 or the date immediately preceding the 2023 annual meeting of stockholders."}],"balance_after":167937,"derivative":{"exercise_price":2.98,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":167937},"source":{"system":"sec-edgar","filing":"0001326110-22-000047","document":"wf-form4_165534220571595.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611022000047/wf-form4_165534220571595.xml","form_type":"4"}},{"id":2235552,"issuer":{"id":109592,"kind":"organization","name":"NantHealth, Inc.","symbol":"NHIQ"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:29:26.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.5823,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-021909","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1371407/000089924322021909/doc4.xml","form_type":"4"}},{"id":2624739,"issuer":{"id":109592,"kind":"organization","name":"NantHealth, Inc.","symbol":"NHIQ"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-26T22:04:27.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date."}],"balance_after":100000,"derivative":{"exercise_price":2.65,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-21-029926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1371407/000089924321029926/doc4.xml","form_type":"4"}},{"id":2669965,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T22:31:22.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":26064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 10, 2022 or the date immediately preceding the 2022 annual meeting of stockholders."}],"balance_after":26064,"derivative":{"exercise_price":14.91,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":26064},"source":{"system":"sec-edgar","filing":"0001209191-21-040343","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121040343/doc4.xml","form_type":"4"}},{"id":3113216,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T22:19:36.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 10, 2021 or the date immediately preceding the 2021 annual meeting of stockholders."}],"balance_after":100000,"derivative":{"exercise_price":6.21,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-036030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919120036030/doc4.xml","form_type":"4"}},{"id":3134808,"issuer":{"id":109592,"kind":"organization","name":"NantHealth, Inc.","symbol":"NHIQ"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-26T21:16:41.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date."}],"balance_after":100000,"derivative":{"exercise_price":2.52,"expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-20-014199","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1371407/000089924320014199/doc4.xml","form_type":"4"}},{"id":3487417,"issuer":{"id":109592,"kind":"organization","name":"NantHealth, Inc.","symbol":"NHIQ"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-17T23:37:19.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":301908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date."}],"balance_after":301908,"derivative":{"exercise_price":0.6093,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":301908},"source":{"system":"sec-edgar","filing":"0000899243-19-017243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1371407/000089924319017243/doc4.xml","form_type":"4"}},{"id":3496973,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T20:35:04.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":92592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award will vest on the earlier to occur of June 6, 2020 or the date immediately preceding the 2020 annual meeting of stockholders."}],"balance_after":193667,"source":{"system":"sec-edgar","filing":"0001209191-19-035558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919119035558/doc4.xml","form_type":"4"}},{"id":3821739,"issuer":{"id":109592,"kind":"organization","name":"NantHealth, Inc.","symbol":"NHIQ"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-07T20:50:20.000Z","date":"2018-09-06","kind":"grant","acquired":true,"shares":52910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") is the economic equivalent of one share of NantHealth, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"The RSUs shall vest on the earlier of (i) the one year anniversary of the date the RSU award is granted, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, in each case, subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":148780,"source":{"system":"sec-edgar","filing":"0000899243-18-024013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1371407/000089924318024013/doc4.xml","form_type":"4"}},{"id":3821738,"issuer":{"id":109592,"kind":"organization","name":"NantHealth, Inc.","symbol":"NHIQ"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-07T20:50:20.000Z","date":"2018-09-06","kind":"grant","acquired":true,"shares":45002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") is the economic equivalent of one share of NantHealth, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through each applicable vesting date, 33,751 RSUs shall be vested as of September 6, 2018, and the remaining 11,251 RSUs shall vest in installments as follows: 3,750 RSUs shall vest on each of December 7, 2018 and March 7, 2019, and 3,751 RSUs shall vest on June 7, 2019."}],"balance_after":95870,"source":{"system":"sec-edgar","filing":"0000899243-18-024013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1371407/000089924318024013/doc4.xml","form_type":"4"}},{"id":3898278,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T20:15:00.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":27322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award will vest on the earlier to occur of June 7, 2019 or the date immediately preceding the 2019 annual meeting of stockholders."}],"balance_after":101075,"source":{"system":"sec-edgar","filing":"0001209191-18-036919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919118036919/doc4.xml","form_type":"4"}},{"id":4168745,"issuer":{"id":109592,"kind":"organization","name":"NantHealth, Inc.","symbol":"NHIQ"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-08T22:18:03.000Z","date":"2017-11-06","kind":"grant","acquired":true,"shares":50868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") is the economic equivalent of one share of NantHealth, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through each applicable vesting date, 21,195 RSUs shall be vested as of November 6, 2017, and the remaining 29,673 RSUs shall vest in equal installments on each three-month anniversary of the Vesting Commencement Date over a period of twenty-one (21) months after the Vesting Commencement Date (i.e., 4,239 RSUs shall vest on each of December 7, 2017, March 7, 2018, June 7, 2018, September 7, 2018, December 7, 2018, March 7, 2019 and June 7, 2019)."}],"balance_after":50868,"source":{"system":"sec-edgar","filing":"0000899243-17-025617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1371407/000089924317025617/doc4.xml","form_type":"4"}},{"id":4283473,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39629,"kind":"person","name":"BLASZYK MICHAEL D","position":1,"cik":"0001371407","reported_name":"BLASZYK MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-13T20:09:36.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":23753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the one year anniversary of the vesting commencement date on the same day of the month as the vesting commencement date. The vesting commencement date for this award is June 9, 2017."}],"balance_after":73753,"source":{"system":"sec-edgar","filing":"0001209191-17-039429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919117039429/doc4.xml","form_type":"4"}}]}